Topline results from Phase 2 ZEPHYR trial of ML-007C-MA for schizophrenia expected in the second half of 2026Topline results from…
BEIJING, Nov. 29, 2025 /PRNewswire/ -- In east China coastal city of Wenzhou, a conference focusing on latest discoveries about Shuomen ancient…
Company confirms 12 patients enrolled in Phase 2 THIO-101 to date as expansion trial adds new countries Posters for Phase…
The Summit highlights how collaboration, trust, and digital innovation are shaping India's evolution into a global pharma powerhouse committed to…
November 19, 2025 17:44 ET | Source: Profusa, Inc. Recapitalization reduced net debt to $14 million as of October 31;…
XI'AN, China, Nov. 19, 2025 /PRNewswire/ -- Shanghai Kehua Bio-engineering Co., Ltd. (KHB), a global provider of in-vitro diagnostic (IVD) solutions, is…
Ahmednagar Leads Emerging Cities; Bengaluru Holds Metro Top Spot MUMBAI, India, Nov. 13, 2025 /PRNewswire/ -- Dun & Bradstreet, a…
MUMBAI, India, Nov. 11, 2025 /PRNewswire/ -- Dun & Bradstreet, a global leader in business decisioning data and analytics, has…
~AI Adoption Emerges as a Key Catalyst for Commercial Resilience~ LEHI, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Sirion, the…
BEIJING, Nov. 4, 2025 /PRNewswire/ -- The 5th World Health Forum convened in Beijing on November 1, gathering nearly 400…